title: Verapamil-induced parkinsonism.
authors.affiliation: Centro de Salud Carlet, Valencia, Spain.
authors.forename: M D
authors.initials: MD
authors.lastname: Padrell
authors.forename: M
authors.initials: M
authors.lastname: Navarro
authors.forename: C C
authors.initials: CC
authors.lastname: Faura
authors.forename: J F
authors.initials: JF
authors.lastname: Horga
mesh_terms: D000368:Aged; D005260:Female; D006801:Humans; D006973:Hypertension / Q000188:drug therapy; D010302:Parkinson Disease, Secondary / Q000139:chemically induced*; D014665:Vasodilator Agents / Q000009:adverse effects*; D014700:Verapamil / Q000009:adverse effects*
chemical_list: D014665:Vasodilator Agents; D014700:Verapamil